12 October 2017 | Cohort profile for the MASTERMIND study: Using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with Type 2 diabetes | Rodgers, LR; Weedon, MN; Henley, WE; et al. |
1 May 2019 | Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors | Warrington, NM; Beaumont, RN; Horikoshi, M; et al. |
6 April 2016 | Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c? | Jones, AG; Lonergan, M; Henley, WE; et al. |
30 January 2018 | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic | Clissold, RL; Fulford, J; Hudson, M; et al. |
20 February 2018 | Genetic risk scores in adult-onset type 1 diabetes - Authors' reply | Thomas, NJ; Jones, SE; Weedon, MN; et al. |
18 December 2019 | Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K ATP -channel pathways | Bowman, P; McDonald, TJ; Knight, BA; et al. |
18 September 2018 | A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | Shepherd, MH; Shields, BM; Hudson, M; et al. |
20 August 2019 | Clusters provide a better holistic view of type 2 diabetes than simple clinical features – Authors' reply | Dennis, JM; Shields, BM; Henley, WE; et al. |
28 April 2016 | Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis | Hope, SV; Wienand-Barnett, S; Shepherd, M; et al. |
23 October 2014 | Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine | Jones, AG; Shields, BM; Hyde, CJ; et al. |